Dale and Betty Bumpers Vaccine Research Center search   
Vaccines for Life
Office of the Director
Research Laboratories
Clinical Studies
Collaboration and Funding
Publications News Seminars Meetings Employment

VRC Home

Vaccine Research Center
Scientific Updates

Smallpox Vaccine Development
The Vaccine Research Center is currently testing Modified Vaccinia Ankara (MVA) as an attenuated poxvirus with the potential to protect against vaccinia (the virus used to vaccinate against smallpox) or variola (the virus that causes smallpox). The vaccine was provided by Therion Biologics Corporation as part of a collaboration with the VRC. Two Phase I clinical trials are now underway testing MVA as a component of a safer smallpox vaccine in both vaccinia naïve and vaccinia immune populations.

 

 

 
National Institutes of Health logo

Department of Health and Human Services / National Institutes of Health / National Institute of Allergy and Infectious Diseases
Vaccine Research Center / 40 Convent Drive / Bethesda, Maryland 20892
Contact Us: vrcwebnotification@mail.nih.gov / Directions and Maps / Site Map

Office of the Director | Research Laboratories | Clinical Studies | Collaboration and Funding
NIAID Website Privacy Statement | NIAID Website Accessibility Statement

Last updated 06.08.04 (alt)

 National Institute of Allergy and Infectious Disease logo